
Ferrer, Leti and Oryzon to collaborate in R&D
Catalan Economy
21 Nov 2009
Pharmaceutical companies Ferrer and Leti and biotech firm Oryzon have announced the creation of the Oncochip alliance to further develop cancer research in Catalonia. Madrid-based Ingenasa and Navarra’s CIMA are also to participate in the project.
With a budget of over EUR 20 million, Oncochip will focus on the design of therapies for early diagnosis of ovarian cancer, melanoma and colon cancer. Oryzon specializes in the detection of cancer biomarkers and is already working with Reig Jofré on uterine cancer research.
Ferrer, Leti and Oryzon also plan to create a new partnership next year to develop nanotechnology projects.
Source: Expansión Cataluña 16/11/2009
Related News and Success stories.
-
07 May 2025
Barcelona, named Europe’s 4th Best City in 2025
-
24 Apr 2025
5 Reasons to Choose Barcelona-Catalonia for Your Life Sciences Expansion
-
14 Apr 2025
Catalonia takes over the presidency of the Four Motors for Europe
-
09 Apr 2025
Catalonia will invest €400 million in InnoFAB, a center for advanced semiconductor development